Global Anticoagulants Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Anticoagulants will have significant change from previous year. According to our latest study, the global Anticoagulants market size is USD million in 2022 from USD 25390 million in 2021, with a change of % between 2021 and 2022. The global Anticoagulants market size will reach USD 35420 million in 2028, growing at a CAGR of 4.9% over the analysis period.
The United States Anticoagulants market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anticoagulants market, reaching US$ million by the year 2028. As for the Europe Anticoagulants landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Anticoagulants players cover Sanofi, Bristol-Myers Squibb, Bayer, and Johnson & Johnson., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anticoagulants market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Platelet Aggregation Inhibitors (PAI)
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Direct Factor Xa Inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
VTE
ACS/MI
AF
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson.
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
Pfizer
Aspen
The Medicines Company
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anticoagulants Market Size 2017-2028
2.1.2 Anticoagulants Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Anticoagulants Segment by Type
2.2.1 Platelet Aggregation Inhibitors (PAI)
2.2.2 Low-Molecular-Weight Heparin (LMWH)
2.2.3 Direct Thrombin Inhibitor (DTI)
2.2.4 Direct Factor Xa Inhibitors (DFXa)
2.2.5 Vitamin K antagonists (VKA)
2.2.6 Others
2.3 Anticoagulants Market Size by Type
2.3.1 Anticoagulants Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Anticoagulants Market Size Market Share by Type (2017-2022)
2.4 Anticoagulants Segment by Application
2.4.1 VTE
2.4.2 ACS/MI
2.4.3 AF
2.4.4 Others
2.5 Anticoagulants Market Size by Application
2.5.1 Anticoagulants Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Anticoagulants Market Size Market Share by Application (2017-2022)
3 Anticoagulants Market Size by Player
3.1 Anticoagulants Market Size Market Share by Players
3.1.1 Global Anticoagulants Revenue by Players (2020-2022)
3.1.2 Global Anticoagulants Revenue Market Share by Players (2020-2022)
3.2 Global Anticoagulants Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anticoagulants by Regions
4.1 Anticoagulants Market Size by Regions (2017-2022)
4.2 Americas Anticoagulants Market Size Growth (2017-2022)
4.3 APAC Anticoagulants Market Size Growth (2017-2022)
4.4 Europe Anticoagulants Market Size Growth (2017-2022)
4.5 Middle East & Africa Anticoagulants Market Size Growth (2017-2022)
5 Americas
5.1 Americas Anticoagulants Market Size by Country (2017-2022)
5.2 Americas Anticoagulants Market Size by Type (2017-2022)
5.3 Americas Anticoagulants Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anticoagulants Market Size by Region (2017-2022)
6.2 APAC Anticoagulants Market Size by Type (2017-2022)
6.3 APAC Anticoagulants Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anticoagulants by Country (2017-2022)
7.2 Europe Anticoagulants Market Size by Type (2017-2022)
7.3 Europe Anticoagulants Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anticoagulants by Region (2017-2022)
8.2 Middle East & Africa Anticoagulants Market Size by Type (2017-2022)
8.3 Middle East & Africa Anticoagulants Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Anticoagulants Market Forecast
10.1 Global Anticoagulants Forecast by Regions (2023-2028)
10.1.1 Global Anticoagulants Forecast by Regions (2023-2028)
10.1.2 Americas Anticoagulants Forecast
10.1.3 APAC Anticoagulants Forecast
10.1.4 Europe Anticoagulants Forecast
10.1.5 Middle East & Africa Anticoagulants Forecast
10.2 Americas Anticoagulants Forecast by Country (2023-2028)
10.2.1 United States Anticoagulants Market Forecast
10.2.2 Canada Anticoagulants Market Forecast
10.2.3 Mexico Anticoagulants Market Forecast
10.2.4 Brazil Anticoagulants Market Forecast
10.3 APAC Anticoagulants Forecast by Region (2023-2028)
10.3.1 China Anticoagulants Market Forecast
10.3.2 Japan Anticoagulants Market Forecast
10.3.3 Korea Anticoagulants Market Forecast
10.3.4 Southeast Asia Anticoagulants Market Forecast
10.3.5 India Anticoagulants Market Forecast
10.3.6 Australia Anticoagulants Market Forecast
10.4 Europe Anticoagulants Forecast by Country (2023-2028)
10.4.1 Germany Anticoagulants Market Forecast
10.4.2 France Anticoagulants Market Forecast
10.4.3 UK Anticoagulants Market Forecast
10.4.4 Italy Anticoagulants Market Forecast
10.4.5 Russia Anticoagulants Market Forecast
10.5 Middle East & Africa Anticoagulants Forecast by Region (2023-2028)
10.5.1 Egypt Anticoagulants Market Forecast
10.5.2 South Africa Anticoagulants Market Forecast
10.5.3 Israel Anticoagulants Market Forecast
10.5.4 Turkey Anticoagulants Market Forecast
10.5.5 GCC Countries Anticoagulants Market Forecast
10.6 Global Anticoagulants Forecast by Type (2023-2028)
10.7 Global Anticoagulants Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Anticoagulants Product Offered
11.1.3 Sanofi Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Information
11.2.2 Bristol-Myers Squibb Anticoagulants Product Offered
11.2.3 Bristol-Myers Squibb Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bristol-Myers Squibb Main Business Overview
11.2.5 Bristol-Myers Squibb Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Anticoagulants Product Offered
11.3.3 Bayer Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Johnson & Johnson.
11.4.1 Johnson & Johnson. Company Information
11.4.2 Johnson & Johnson. Anticoagulants Product Offered
11.4.3 Johnson & Johnson. Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson & Johnson. Main Business Overview
11.4.5 Johnson & Johnson. Latest Developments
11.5 Genentech (Roche)
11.5.1 Genentech (Roche) Company Information
11.5.2 Genentech (Roche) Anticoagulants Product Offered
11.5.3 Genentech (Roche) Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Genentech (Roche) Main Business Overview
11.5.5 Genentech (Roche) Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Anticoagulants Product Offered
11.6.3 Boehringer Ingelheim Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 Lilly
11.7.1 Lilly Company Information
11.7.2 Lilly Anticoagulants Product Offered
11.7.3 Lilly Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Lilly Main Business Overview
11.7.5 Lilly Latest Developments
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Information
11.8.2 Daiichi Sankyo Anticoagulants Product Offered
11.8.3 Daiichi Sankyo Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Daiichi Sankyo Main Business Overview
11.8.5 Daiichi Sankyo Latest Developments
11.9 Otsuka
11.9.1 Otsuka Company Information
11.9.2 Otsuka Anticoagulants Product Offered
11.9.3 Otsuka Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Otsuka Main Business Overview
11.9.5 Otsuka Latest Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Information
11.10.2 AstraZeneca Anticoagulants Product Offered
11.10.3 AstraZeneca Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 AstraZeneca Main Business Overview
11.10.5 AstraZeneca Latest Developments
11. Pfizer
11.11.1 Pfizer Company Information
11.11.2 Pfizer Anticoagulants Product Offered
11.11.3 Pfizer Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Pfizer Main Business Overview
11.11.5 Pfizer Latest Developments
11.12 Aspen
11.12.1 Aspen Company Information
11.12.2 Aspen Anticoagulants Product Offered
11.12.3 Aspen Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Aspen Main Business Overview
11.12.5 Aspen Latest Developments
11.13 The Medicines Company
11.13.1 The Medicines Company Company Information
11.13.2 The Medicines Company Anticoagulants Product Offered
11.13.3 The Medicines Company Anticoagulants Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 The Medicines Company Main Business Overview
11.13.5 The Medicines Company Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Anticoagulants Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Platelet Aggregation Inhibitors (PAI)
Table 3. Major Players of Low-Molecular-Weight Heparin (LMWH)
Table 4. Major Players of Direct Thrombin Inhibitor (DTI)
Table 5. Major Players of Direct Factor Xa Inhibitors (DFXa)
Table 6. Major Players of Vitamin K antagonists (VKA)
Table 7. Major Players of Others
Table 8. Anticoagulants Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Anticoagulants Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Anticoagulants Market Size Market Share by Type (2017-2022)
Table 11. Anticoagulants Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Anticoagulants Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Anticoagulants Market Size Market Share by Application (2017-2022)
Table 14. Global Anticoagulants Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Anticoagulants Revenue Market Share by Player (2020-2022)
Table 16. Anticoagulants Key Players Head office and Products Offered
Table 17. Anticoagulants Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Anticoagulants Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Anticoagulants Market Size Market Share by Regions (2017-2022)
Table 22. Americas Anticoagulants Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Anticoagulants Market Size Market Share by Country (2017-2022)
Table 24. Americas Anticoagulants Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Anticoagulants Market Size Market Share by Type (2017-2022)
Table 26. Americas Anticoagulants Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Anticoagulants Market Size Market Share by Application (2017-2022)
Table 28. APAC Anticoagulants Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Anticoagulants Market Size Market Share by Region (2017-2022)
Table 30. APAC Anticoagulants Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Anticoagulants Market Size Market Share by Type (2017-2022)
Table 32. APAC Anticoagulants Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Anticoagulants Market Size Market Share by Application (2017-2022)
Table 34. Europe Anticoagulants Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Anticoagulants Market Size Market Share by Country (2017-2022)
Table 36. Europe Anticoagulants Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Anticoagulants Market Size Market Share by Type (2017-2022)
Table 38. Europe Anticoagulants Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Anticoagulants Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Anticoagulants Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Anticoagulants Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Anticoagulants Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Anticoagulants Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Anticoagulants Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Anticoagulants Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Anticoagulants
Table 47. Key Market Challenges & Risks of Anticoagulants
Table 48. Key Industry Trends of Anticoagulants
Table 49. Global Anticoagulants Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Anticoagulants Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Anticoagulants Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Anticoagulants Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Anticoagulants Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Anticoagulants Market Size Market Share Forecast by Application (2023-2028)
Table 55. Sanofi Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 56. Sanofi Anticoagulants Product Offered
Table 57. Sanofi Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Sanofi Main Business
Table 59. Sanofi Latest Developments
Table 60. Bristol-Myers Squibb Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 61. Bristol-Myers Squibb Anticoagulants Product Offered
Table 62. Bristol-Myers Squibb Main Business
Table 63. Bristol-Myers Squibb Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Bristol-Myers Squibb Latest Developments
Table 65. Bayer Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 66. Bayer Anticoagulants Product Offered
Table 67. Bayer Main Business
Table 68. Bayer Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. Bayer Latest Developments
Table 70. Johnson & Johnson. Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 71. Johnson & Johnson. Anticoagulants Product Offered
Table 72. Johnson & Johnson. Main Business
Table 73. Johnson & Johnson. Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. Johnson & Johnson. Latest Developments
Table 75. Genentech (Roche) Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 76. Genentech (Roche) Anticoagulants Product Offered
Table 77. Genentech (Roche) Main Business
Table 78. Genentech (Roche) Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Genentech (Roche) Latest Developments
Table 80. Boehringer Ingelheim Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 81. Boehringer Ingelheim Anticoagulants Product Offered
Table 82. Boehringer Ingelheim Main Business
Table 83. Boehringer Ingelheim Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 84. Boehringer Ingelheim Latest Developments
Table 85. Lilly Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 86. Lilly Anticoagulants Product Offered
Table 87. Lilly Main Business
Table 88. Lilly Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 89. Lilly Latest Developments
Table 90. Daiichi Sankyo Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 91. Daiichi Sankyo Anticoagulants Product Offered
Table 92. Daiichi Sankyo Main Business
Table 93. Daiichi Sankyo Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 94. Daiichi Sankyo Latest Developments
Table 95. Otsuka Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 96. Otsuka Anticoagulants Product Offered
Table 97. Otsuka Main Business
Table 98. Otsuka Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 99. Otsuka Latest Developments
Table 100. AstraZeneca Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 101. AstraZeneca Anticoagulants Product Offered
Table 102. AstraZeneca Main Business
Table 103. AstraZeneca Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. AstraZeneca Latest Developments
Table 105. Pfizer Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 106. Pfizer Anticoagulants Product Offered
Table 107. Pfizer Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 108. Pfizer Main Business
Table 109. Pfizer Latest Developments
Table 110. Aspen Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 111. Aspen Anticoagulants Product Offered
Table 112. Aspen Main Business
Table 113. Aspen Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 114. Aspen Latest Developments
Table 115. The Medicines Company Details, Company Type, Anticoagulants Area Served and Its Competitors
Table 116. The Medicines Company Anticoagulants Product Offered
Table 117. The Medicines Company Main Business
Table 118. The Medicines Company Anticoagulants Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 119. The Medicines Company Latest Developments
List of Figures
Figure 1. Anticoagulants Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anticoagulants Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Anticoagulants Market Size Market Share by Type in 2021
Figure 7. Anticoagulants in VTE
Figure 8. Global Anticoagulants Market: VTE (2017-2022) & ($ Millions)
Figure 9. Anticoagulants in ACS/MI
Figure 10. Global Anticoagulants Market: ACS/MI (2017-2022) & ($ Millions)
Figure 11. Anticoagulants in AF
Figure 12. Global Anticoagulants Market: AF (2017-2022) & ($ Millions)
Figure 13. Anticoagulants in Others
Figure 14. Global Anticoagulants Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Anticoagulants Market Size Market Share by Application in 2021
Figure 16. Global Anticoagulants Revenue Market Share by Player in 2021
Figure 17. Global Anticoagulants Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Anticoagulants Market Size 2017-2022 ($ Millions)
Figure 19. APAC Anticoagulants Market Size 2017-2022 ($ Millions)
Figure 20. Europe Anticoagulants Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Anticoagulants Market Size 2017-2022 ($ Millions)
Figure 22. Americas Anticoagulants Value Market Share by Country in 2021
Figure 23. Americas Anticoagulants Consumption Market Share by Type in 2021
Figure 24. Americas Anticoagulants Market Size Market Share by Application in 2021
Figure 25. United States Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Anticoagulants Market Size Market Share by Region in 2021
Figure 30. APAC Anticoagulants Market Size Market Share by Application in 2021
Figure 31. China Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Anticoagulants Market Size Market Share by Country in 2021
Figure 38. Europe Anticoagulants Market Size Market Share by Type in 2021
Figure 39. Europe Anticoagulants Market Size Market Share by Application in 2021
Figure 40. Germany Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Anticoagulants Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Anticoagulants Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Anticoagulants Market Size Market Share by Application in 2021
Figure 48. Egypt Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Anticoagulants Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 54. APAC Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 55. Europe Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 57. United States Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 58. Canada Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 61. China Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 62. Japan Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 63. Korea Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 65. India Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 66. Australia Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 67. Germany Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 68. France Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 69. UK Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 70. Italy Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 71. Russia Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 72. Spain Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 75. Israel Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Anticoagulants Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Anticoagulants Market Size 2023-2028 ($ Millions)
